Mustang Bio Inc. - notizie pubblicate 187 - letture 1.952


Mustang Bio Inc.

MUSTANG BIO INC.

Information Statement - Form DEF 14C

Securities and exchange commission washington, d.c. 20549 schedule 14c information information statement pursuant to section 14(c) of the securities exchange act of 1934 check th ...

10.07.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Material Agreement Form 8 K

Item 1.01. entry into a material definitive agreement. background of the ubrigene transaction as previously reported, on may 18, 2023, mustang bio, inc. (the "company") e ...

03.07.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Supplemental Prospectus - Form 424B5

Filed pursuant to rule 424(b)(5) registration no. 333-279891 amendment no. 1 dated july 3, 2024 to prospectus supplement dated june 19, 2024 (to prospectus dated june 12, 2024) mus ...

03.07.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Preliminary Information Statement - Form PRE 14C

Securities and exchange commission washington, d.c. 20549 schedule 14c information information statement pursuant to section 14(c) of the securities exchange act of 1934 check th ...

28.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

28.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Notice of Sales of Unregistered Securities - Form D

Sec form d the securities and exchange commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. the reader shou ...

24.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At the Market Under Nasdaq Rules Form 8 K

Mustang bio announces $2.5 million registered direct offering priced at-the-market under nasdaq rules worcester, mass., june 20, 2024 (globe newswire) -- mustang bio, inc. ("m ...

24.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At the Market Under Nasdaq Rules

Mustang bio announces closing of $2.5 million registered direct offering priced at-the-market under nasdaq rules june 21, 2024 • 4:01 pm edt download as pdf worcester, mass., jun ...

21.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Supplemental Prospectus - Form 424B5

Filed pursuant to rule 424(b)(5) registration no. 333-279891 prospectus supplement to the prospectus dated june 12, 2024 3,025,000 shares of common stock 3,105,000 pre-funded warra ...

21.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At the Market Under Nasdaq Rules

Mustang bio announces $2.5 million registered direct offering priced at-the-market under nasdaq rules june 20, 2024 • 8:00 am edt download as pdf worcester, mass., june 20, 2024 ...

20.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Supplemental Prospectus - Form 424B5

Filed pursuant to rule 424(b)(5) registration no. 333-279891 prospectus supplement dated june 19, 2024 (to prospectus dated june 12, 2024) mustang bio, inc. this prospectus supplem ...

20.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB 106, CD20 Targeted Autologous CAR T Therapy

Mustang bio announces favorable efficacy and safety data from complete waldenstrom macroglobulinemia cohort of phase 1/2 clinical trial of mb-106, cd20-targeted autologous car-t th ...

17.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Notice of Effectiveness - Form EFFECT

Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: june 12, 2024 4:00 p.m. form: s-3 cik: 0 ...

13.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Material Agreement Form 8 K

Item 1.01. entry into a material definitive agreement. on may 31, 2024, mustang bio, inc. (the "company") entered into an at the market offering agreement (the "offe ...

06.06.2024
Mustang Bio Inc.

MUSTANG BIO INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

05.06.2024
Condividi